Atrys Health Statistics

Total Valuation

Atrys Health has a market cap or net worth of EUR 240.72 million. The enterprise value is 478.14 million.

Market Cap	240.72M
Enterprise Value	478.14M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Atrys Health has 75.94 million shares outstanding. The number of shares has increased by 6.53% in one year.

Current Share Class	n/a
Shares Outstanding	75.94M
Shares Change (YoY)	+6.53%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.70%
Owned by Institutions (%)	14.90%
Float	41.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	121.55
PS Ratio	1.14
PB Ratio	0.89
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.70, with an EV/FCF ratio of -27.93.

EV / Earnings	-12.24
EV / Sales	2.26
EV / EBITDA	31.70
EV / EBIT	n/a
EV / FCF	-27.93

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.92.

Current Ratio	0.98
Quick Ratio	0.80
Debt / Equity	0.92
Debt / EBITDA	16.60
Debt / FCF	-14.62
Interest Coverage	-0.02

Financial Efficiency

Return on equity (ROE) is -10.79% and return on invested capital (ROIC) is -0.06%.

Return on Equity (ROE)	-10.79%
Return on Assets (ROA)	-0.05%
Return on Capital (ROIC)	-0.06%
Revenue Per Employee	101,298
Profits Per Employee	-18,745
Employee Count	2,061
Asset Turnover	0.33
Inventory Turnover	98.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.86% in the last 52 weeks. The beta is 0.58, so Atrys Health's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-14.86%
50-Day Moving Average	3.18
200-Day Moving Average	3.32
Relative Strength Index (RSI)	54.95
Average Volume (20 Days)	42,494

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Atrys Health had revenue of EUR 211.11 million and -39.07 million in losses. Loss per share was -0.51.

Revenue	211.11M
Gross Profit	55.44M
Operating Income	-506,000
Pretax Income	-32.18M
Net Income	-39.07M
EBITDA	8.21M
EBIT	-506,000
Loss Per Share	-0.51

Full Income Statement

Balance Sheet

The company has 12.81 million in cash and 250.32 million in debt, giving a net cash position of -237.51 million or -3.13 per share.

Cash & Cash Equivalents	12.81M
Total Debt	250.32M
Net Cash	-237.51M
Net Cash Per Share	-3.13
Equity (Book Value)	271.10M
Book Value Per Share	3.57
Working Capital	-2.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.67 million and capital expenditures -4.44 million, giving a free cash flow of -17.12 million.

Operating Cash Flow	-12.67M
Capital Expenditures	-4.44M
Free Cash Flow	-17.12M
FCF Per Share	-0.23

Full Cash Flow Statement

Margins

Gross margin is 26.26%, with operating and profit margins of -0.24% and -18.51%.

Gross Margin	26.26%
Operating Margin	-0.24%
Pretax Margin	-15.25%
Profit Margin	-18.51%
EBITDA Margin	3.89%
EBIT Margin	-0.24%
FCF Margin	n/a

Dividends & Yields

Atrys Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.53%
Shareholder Yield	-6.53%
Earnings Yield	-16.23%
FCF Yield	-7.11%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Atrys Health has an Altman Z-Score of 0.69. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.69
Piotroski F-Score	n/a